Results 91 to 100 of about 27,398 (275)

Comparisons of computation cost and aggregate signature size.

open access: yes, 2014
Comparisons of computation cost and aggregate signature size.
Qian Zhan (647136)   +2 more
core   +1 more source

New certificateless aggregate signature scheme with universal designated verifier

open access: yesTongxin xuebao, 2017
Certificateless aggregate signature(CLAS) schemes with universal designated verifier had been widely applied in resource-constrained wireless mobile networks,because they could not only solve the problems of the certificate management and private key ...
Zhi-yan XU   +3 more
doaj   +2 more sources

Sequential Aggregate Signatures Made Shorter [PDF]

open access: yes, 2013
Sequential aggregate signature (SAS) is a special type of public-key signature that allows a signer to add his signature into a previous aggregate signature in sequential order. In this case, since many public keys are used and many signatures are employed and compressed, it is important to reduce the sizes of signatures and public keys.
Kwangsu Lee   +2 more
openaire   +2 more sources

COMP–PMEPA1 axis promotes epithelial‐to‐mesenchymal transition in breast cancer cells

open access: yesMolecular Oncology, EarlyView.
This study reveals that cartilage oligomeric matrix protein (COMP) promotes epithelial‐to‐mesenchymal transition (EMT) in breast cancer. We identify PMEPA1 (protein TMEPAI) as a novel COMP‐binding partner that mediates EMT via binding to the TSP domains of COMP, establishing the COMP–PMEPA1 axis as a key EMT driver in breast cancer.
Konstantinos S. Papadakos   +6 more
wiley   +1 more source

Signature of an aggregation-prone conformation of tau

open access: yesScientific Reports, 2017
AbstractThe self-assembly of the microtubule associated tau protein into fibrillar cell inclusions is linked to a number of devastating neurodegenerative disorders collectively known as tauopathies. The mechanism by which tau self-assembles into pathological entities is a matter of much debate, largely due to the lack of direct experimental insights ...
Eschmann, Neil   +8 more
openaire   +5 more sources

Pre‐analytical optimization of cell‐free DNA and extracellular vesicle‐derived DNA for mutation detection in liquid biopsies

open access: yesMolecular Oncology, EarlyView.
Pre‐analytical handling critically determines liquid biopsy performance. This study defines practical best‐practice conditions for cell‐free DNA (cfDNA) and extracellular vesicle–derived DNA (evDNA), showing how processing time, storage conditions, tube type, and plasma input volume affect DNA integrity and mutation detection.
Jonas Dohmen   +11 more
wiley   +1 more source

EDNRB‐dependent endothelin signaling reduces proliferation and promotes proneural‐to‐mesenchymal transition in gliomas

open access: yesMolecular Oncology, EarlyView.
Glioma cells mainly express the endothelin receptor EDNRB, while EDNRA is restricted to a perivascular tumor subpopulation. Endothelin signaling reduces glioma cell proliferation while promoting migration and a proneural‐to‐mesenchymal transition associated with poor prognosis. This pathway activates Ca2+, K+, ERK, and STAT3 signalings and is regulated
Donovan Pineau   +36 more
wiley   +1 more source

ID-Based Sequential Aggregate Signatures

open access: yesJournal of Software, 2011
An aggregate signature provides a method for combining n signatures of n different messages from n different signers into one signature of unit length. The main benefit of such schemes is that they allow bandwidth and computational savings.
Xiangguo Cheng   +3 more
openaire   +1 more source

Interrogating the immune landscape of microsatellite stable RAS‐mutated colon cancer

open access: yesMolecular Oncology, EarlyView.
COLOSSUS project RAS‐mutated MSS colon cancer study explored transcriptomics and immune cell density by immunohistochemistry (IHC), Immunoscore (IS), ISIC/TuLIS scores, mutation counts, and detected different prevalences but similar microenvironment composition across immune markers with clinical relevance for future immunotherapy combination ...
Rodrigo Dienstmann   +61 more
wiley   +1 more source

Home - About - Disclaimer - Privacy